AzTrials
AzTrials

Strabismic AmblyopiaAMPELNCT02555384

AMblyopia Treatment Through PErceptual Training in Children (AMPEL)

A study testing crowded drawing task and uncrowded drawing task in people with Strabismic Amblyopia, run by University of Basel.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Amblyopia, affects 4% of the population. In the presence of a normal retina and optic nerve, the visual cortex does not develop normally secondary to the amblyopic eye being at a disadvantage in the sensitive period such as in strabismus. Read more about this study

Who is it for?
Ages 4 to 8 years
Conditions the study is for
Strabismic Amblyopia
What is being tested?
crowded drawing task and uncrowded drawing task
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
0 participants
Where
No sites listed yet
Study dates
Jan 2020to 30 Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • strabismic amblyopia
  • cycloplegic refraction corrected at least 3 months prior to enrolment
  • Reliable test results for two previous examinations
  • absence of ocular conditions other than strabismus, amblyopia and corrected refractive error

Who cannot join

  • inability to perform reliably when examined
  • inability to draw
  • unstable visual results on 2 previous examinations

About this study

Official title: Improving Visual Functions in Young Children With Amblyopia Through Perceptual Learning

Amblyopia, affects 4% of the population. In the presence of a normal retina and optic nerve, the visual cortex does not develop normally secondary to the amblyopic eye being at a disadvantage in the sensitive period such as in strabismus. Amblyopia is associated with visuospatial disorders, and poor to absent stereopsis. Amblyopia is treated by occlusion of the non- amblyopic eye in childhood. The present study aims to evaluate the effectiveness of perceptual learning (PL), that is a training of visual drawing tasks (12 sessions of 30 Minutes duration) with crowding (c) for children with amblyopia compared to an amblyopic control group with a placebo drawing task.

Arm 1: Crowded (PLc)- Training with small spacing Arm 2: Uncrowded (PLu)- Training with large spacing Prior to this, a small group will help optimize parameters such as contrast and distance of visual objects presented

Read the detailed description

Outcome(s):

Primary endpoints: improvement of amblyopia,crowding ratio (CR) and visual acuity before and after training, at 7 weeks, at 6 months Secondary outcome: hand-eye coordination, evaluated with the Beery VMI test before and after training, at 7 weeks, at 6 months Tertiary outcome over 6 years of age: macular structure measured with the OCT before and after training, at 7 weeks, at 6 months

Study design:

Cohort study, randomised controlled trial, single blind, active control, parallel groups

Inclusion / Exclusion criteria:

  • 20 Children included to optimize test criteria (high vs low contrast and spacing).
  • 40 Children for 2-armed study.

Measurements and procedures:

12 sessions (2x per week for 6 weeks, 30 Minutes each) where drawing tasks are performed during their occlusion time.

Arm 1: Crowded - task with small spacing Arm 2: Uncrowded task with large spacing. Prior to this, a small group will help optimize parameters such as contrast and distance of visual objects presented The following parameters are evaluated at onset, at week 7 and at 6 months: visual acuity with and without crowding, the Berry Test and in children over 6 years of age, if possible: a reading task and OCT.

Statistical Considerations:

Patients will be randomized by letting a computer program perform the assignment of children in a certain training group. However, some restrictions will be inserted on the amount of randomization: equal number of children in our training groups, age- and acuity matched groups, equal patching times.

The analysis is aimed at answering the primary question: Can the training reduce crowding and improve visual acuity in children with amblyopia? In order to answer this question, a repeated measures ANOVA is conducted in which the crowding ratio (CR) before and after training will be entered as a within-subjects variable (2 levels: CR pre, and CR post/VA pre, VA post). Training group will be entered as a between subjects variable (2 levels: control and experimental). If there is an interaction effect, post hoc ANOVA's will be conducted to disentangle the effect of training on the CR within training groups.

A secondary question is: Can the training improve hand-eye coordination in children with amblyopia. To this regard the results of the Beery VMI test are being evaluated with a repeated measures ANOVA.

Sample size Calculation. As the crowding ratio (CR) is to be expected more important than VA, only this parameter will be powered.

Main parameter for the power calculation will be the difference (CRd) of the CR at the end of the intervention period compared to the CR at screening.

A CR decrease of 0.3 between "control" and "learning" group is assumed to be of clinical relevance.

The population standard deviation (SD) of CR is assumed to be 0.33. Assuming a moderate correlation coefficient of 0.5 between timepoints, the within subject SD is calculated as sqrt(0.33*0.33*0.5)=0.23. Therefore the SD of CRd is sqrt(2)*0.23=0.33. [Details are described in Sample Sizes for Clinical Trials,Steven A . Julious,Chapman and Hall/CRC 2009].

Based on a sample size of 20 subjects for each study group, there is a power of 88% to detect a CRd decrease of 0.3. This calculation is based on a one-sided T-test (alpha=5%).

GCP Statement: This study will be conducted in compliance with the protocol, the current version of the Declaration of Helsinki, the ICH-GCP or ISO EN 14155 (as far as applicable) as well as all national legal and regulatory requirements.

Being tested
crowded drawing task, uncrowded drawing task
Medical subject headings
Amblyopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • crowded drawing taskOther

    Marking inverted signs on a sheet where symbols are presented close to one another

  • uncrowded drawing taskOther

    Marking inverted signs on a sheet where there is a larger distance between symbols

Study groups in NCT02555384
Study groupRoleWhat they receive
crowded drawing taskActive comparatorchildren will be asked to draw on a pattern presented under crowded viewing conditions.
Receives: Other: crowded drawing task
uncrowded drawing taskPlacebo comparatorchildren will be asked to draw on a pattern presented under uncrowded viewing conditions
Receives: Other: uncrowded drawing task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Crowding Ratio (CR)

    CR= Ratio of crowded versus uncrowded visual acuity. This is compared pre to post treatment

    Measured: 7 weeks

Secondary outcomes (1)
  1. hand-eye coordination

    Outcome of a Beery test

    Measured: 7 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2015 (estimated)
  2. Study startJan 2020 (estimated)
  3. Primary completion30 Nov 2020
  4. Study completion30 Nov 2020

Why it stopped: Inclusion and Exclusion criteria too stringent, no patient coluld be recruited

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02555384
Sponsor's protocol ID
EKNZ2015-264
Acronym
AMPEL
Status last verified
Jun 2023
First submitted
16 Sep 2015
Last updated
23 Jun 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Huurneman B, Boonstra FN, Cox RF, van Rens G, Cillessen AH. Perceptual learning in children with visual impairment improves near visual acuity. Invest Ophthalmol Vis Sci. 2013 Sep 17;54(9):6208-16. doi: 10.1167/iovs.13-12220.

    PubMed 23950157

Questions about this trial

What is this clinical trial studying?

A study testing crowded drawing task and uncrowded drawing task in people with Strabismic Amblyopia, run by University of Basel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 23 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Crowding Ratio (CR) (time frame: 7 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02555384, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in